These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 8904106)

  • 21. Antimicrobial activity of cathelicidin peptides against Burkholderia pseudomallei, the causative agent of melioidosis.
    Sim SH; Liu Y; Tan J; Thong TW; Wang D; Ooi EE; Tan G
    Int J Antimicrob Agents; 2011 Sep; 38(3):270-1. PubMed ID: 21782393
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparison of E test with conventional agar MICs for quinolones.
    Holt HA; Bowker K; Bedford KA; Reeves DS; MacGowan AP
    J Antimicrob Chemother; 1994 Feb; 33(2):356. PubMed ID: 8182022
    [No Abstract]   [Full Text] [Related]  

  • 23. Activity of four fluoroquinolones against 346 strains of enteric pathogens.
    Le Noc P; Bryskier A; Le Noc D; Croizé J
    J Antimicrob Chemother; 1993 Mar; 31(3):447-50. PubMed ID: 8486583
    [No Abstract]   [Full Text] [Related]  

  • 24. In vitro activity of tebipenem against Burkholderia pseudomallei.
    Seenama C; Tiengrim S; Thamlikitkul V
    Int J Antimicrob Agents; 2013 Oct; 42(4):375. PubMed ID: 23978354
    [No Abstract]   [Full Text] [Related]  

  • 25. Sparfloxacin in the treatment of males with urethritis.
    Tanaka M; Matsumoto T; Kumazawa J; Nagayama A
    Eur J Clin Microbiol Infect Dis; 1992 Jul; 11(7):660. PubMed ID: 1327790
    [No Abstract]   [Full Text] [Related]  

  • 26. Disk susceptibility testing for rufloxacin.
    Andrews JM; Wise R
    Eur J Clin Microbiol Infect Dis; 1993 Dec; 12(12):974-6. PubMed ID: 8187800
    [No Abstract]   [Full Text] [Related]  

  • 27. In vitro activity of ceftaroline against Burkholderia pseudomallei.
    Maloney S; Engler C; Norton R
    J Antimicrob Chemother; 2014 Jun; 69(6):1716-8. PubMed ID: 24505090
    [No Abstract]   [Full Text] [Related]  

  • 28. Biological activity of new aza analogues of quinolones.
    Belicová A; Seman M; Milata V; Ilavský D; Ebringer L
    Folia Microbiol (Praha); 1997; 42(3):193-8. PubMed ID: 9246761
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased resistance of enteropathogens to fluoroquinolones in Barcelona, Spain.
    Navarro F; Miró E; Izquierdo C; Mirelis B; Prats G
    Eur J Clin Microbiol Infect Dis; 1993 Aug; 12(8):645-6. PubMed ID: 8223670
    [No Abstract]   [Full Text] [Related]  

  • 30. [Sparfloxacin].
    Enferm Infecc Microbiol Clin; 1998 Jan; 16(1):49-50. PubMed ID: 9542316
    [No Abstract]   [Full Text] [Related]  

  • 31. Finafloxacin overcomes Burkholderia pseudomallei efflux-mediated fluoroquinolone resistance.
    Randall LB; Georgi E; Genzel GH; Schweizer HP
    J Antimicrob Chemother; 2017 Apr; 72(4):1258-1260. PubMed ID: 28039270
    [No Abstract]   [Full Text] [Related]  

  • 32. A structural biology approach enables the development of antimicrobials targeting bacterial immunophilins.
    Begley DW; Fox D; Jenner D; Juli C; Pierce PG; Abendroth J; Muruthi M; Safford K; Anderson V; Atkins K; Barnes SR; Moen SO; Raymond AC; Stacy R; Myler PJ; Staker BL; Harmer NJ; Norville IH; Holzgrabe U; Sarkar-Tyson M; Edwards TE; Lorimer DD
    Antimicrob Agents Chemother; 2014; 58(3):1458-67. PubMed ID: 24366729
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Activity of 15 common antibiotics on 25 strains of Enterobacteriaceae and Pseudomonadaceae: bacteriostatic, bactericidal].
    CLUZEL-NIGAY M; VAURS R; GRAS H; CLUZEL R; CROS G
    Pathol Biol; 1959 Jun; 7():1225-8. PubMed ID: 13810753
    [No Abstract]   [Full Text] [Related]  

  • 34. In vitro activity of tosufloxacin against Pseudomonas pseudomallei, Salmonella spp. and other Enterobacteriaceae.
    Srimuang S; Fugpholngam V; Asvanich K; Chongchitmate A; Tanphaichitra D
    Drugs; 1995; 49 Suppl 2():260. PubMed ID: 8549324
    [No Abstract]   [Full Text] [Related]  

  • 35. In vitro antimicrobial activity of lomefloxacin against staphylococci, enterococci, and Enterobacteriaceae.
    Rossolini GM; Valentini S; Vaiani G; Satta G
    J Chemother; 1989 Jul; 1(4 Suppl):173-6. PubMed ID: 16312356
    [No Abstract]   [Full Text] [Related]  

  • 36. Activity of five fluoroquinolones against 71 isolates of Burkholderia pseudomallei.
    Ho PL; Cheung TK; Kinoshita R; Tse CW; Yuen KY; Chau PY
    J Antimicrob Chemother; 2002 Jun; 49(6):1042-4. PubMed ID: 12039903
    [No Abstract]   [Full Text] [Related]  

  • 37. [Bactericidal activity of quinolones (including sparfloxacin) against Enterococcus; in vitro antagonisms with gentamicin].
    Watine J; Charet JC
    Pathol Biol (Paris); 1997 May; 45(5):430-2. PubMed ID: 9296098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sparfloxacin and other new fluoroquinolones.
    Richard P; Gutmann L
    J Antimicrob Chemother; 1992 Dec; 30(6):739-44. PubMed ID: 1337749
    [No Abstract]   [Full Text] [Related]  

  • 39. In vitro activity of sparfloxacin against selected enterobacteriaceae and pseudomonaceae including Ps. pseudomallei (melioidosis).
    Siristonpun Y; Rojnapisarnvong V; Srimuang S; Tanphaichitra D
    J Chemother; 1995 Nov; 7 Suppl 4():54-5. PubMed ID: 8904106
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.